In vitro and in silico studies reveal antidiabetic properties of arylbenzofurans from the root bark of Morus mesozygia Stapf
Diabetes remains an important disease worldwide with about 500 million patients globally. In tropical Africa, Morus mesozygia is traditionally used in the treatment of diabetes. Biological and phytochemical investigation of the root bark extracts of the plant led to the isolation of a new prenylated...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-02-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1338333/full |
| _version_ | 1797292594462457856 |
|---|---|
| author | Katherine Olabanjo Olufolabo Katherine Olabanjo Olufolabo Kai Lüersen Samuel Ayoolu Oguntimehin Vaderament-A. Nchiozem-Ngnitedem Emmanuel Ayodeji Agbebi Kolade Olatubosun Faloye Divinah Kwamboka Nyamboki Gerald Rimbach Josphat Clement Matasyoh Bernd Schmidt Jones Olanrewaju Moody |
| author_facet | Katherine Olabanjo Olufolabo Katherine Olabanjo Olufolabo Kai Lüersen Samuel Ayoolu Oguntimehin Vaderament-A. Nchiozem-Ngnitedem Emmanuel Ayodeji Agbebi Kolade Olatubosun Faloye Divinah Kwamboka Nyamboki Gerald Rimbach Josphat Clement Matasyoh Bernd Schmidt Jones Olanrewaju Moody |
| author_sort | Katherine Olabanjo Olufolabo |
| collection | DOAJ |
| description | Diabetes remains an important disease worldwide with about 500 million patients globally. In tropical Africa, Morus mesozygia is traditionally used in the treatment of diabetes. Biological and phytochemical investigation of the root bark extracts of the plant led to the isolation of a new prenylated arylbenzofuran named 7-(3-hydroxy-3-methylbutyl)moracin M (1) and two congeners, moracins P (2) and M (3). When compared to acarbose (IC50 = 486 µM), all the isolated compounds are better inhibitors of α-glucosidase with in vitro IC50 values of 16.9, 16.6, and 40.9 µM, respectively. However, they were not active against α-amylase. The compounds also demonstrated moderate inhibition of dipeptidyl peptidase-4 (DPP4). Based on in silico docking studies, all isolates (1, 2, and 3) exhibit binding affinities of −8.7, −9.5, and −8.5 kcal/mol, respectively against α-glucosidase enzyme (PDB: 3AJ7). They are stabilized within the α-glucosidase active site through hydrogen bonds, pi interactions, and hydrophobic interactions. This study provides scientific support for the traditional use of Morus mesozygia in the treatment of diabetes as well as adding to the repository of α-glucosidase inhibitory agents. |
| first_indexed | 2024-03-07T19:58:43Z |
| format | Article |
| id | doaj.art-13e705510abf4b93b741d3f9ccfea557 |
| institution | Directory Open Access Journal |
| issn | 1663-9812 |
| language | English |
| last_indexed | 2024-03-07T19:58:43Z |
| publishDate | 2024-02-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Pharmacology |
| spelling | doaj.art-13e705510abf4b93b741d3f9ccfea5572024-02-28T12:07:00ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122024-02-011510.3389/fphar.2024.13383331338333In vitro and in silico studies reveal antidiabetic properties of arylbenzofurans from the root bark of Morus mesozygia StapfKatherine Olabanjo Olufolabo0Katherine Olabanjo Olufolabo1Kai Lüersen2Samuel Ayoolu Oguntimehin3Vaderament-A. Nchiozem-Ngnitedem4Emmanuel Ayodeji Agbebi5Kolade Olatubosun Faloye6Divinah Kwamboka Nyamboki7Gerald Rimbach8Josphat Clement Matasyoh9Bernd Schmidt10Jones Olanrewaju Moody11Department of Pharmacognosy, Faculty of Pharmacy, Olabisi Onabanjo University, Ago-Iwoye, NigeriaDepartment of Pharmacognosy, Faculty of Pharmacy, University of Ibadan, Ibadan, NigeriaInstitute of Human Nutrition and Food Science, University of Kiel, Kiel, GermanyDepartment of Pharmacognosy, Faculty of Pharmacy, University of Ibadan, Ibadan, NigeriaInstitut für Chemie, University of Potsdam, Potsdam, GermanyDepartment of Pharmacognosy and Natural Products, College of Pharmacy, Afe Babalola University, Ado-Ekiti, NigeriaDepartment of Chemistry, Faculty of Science, Obafemi Awolowo University, Ile Ife, NigeriaDepartment of Chemistry, Faculty of Sciences, Egerton University, Egerton, KenyaInstitute of Human Nutrition and Food Science, University of Kiel, Kiel, GermanyDepartment of Chemistry, Faculty of Sciences, Egerton University, Egerton, KenyaInstitut für Chemie, University of Potsdam, Potsdam, GermanyDepartment of Pharmacognosy, Faculty of Pharmacy, University of Ibadan, Ibadan, NigeriaDiabetes remains an important disease worldwide with about 500 million patients globally. In tropical Africa, Morus mesozygia is traditionally used in the treatment of diabetes. Biological and phytochemical investigation of the root bark extracts of the plant led to the isolation of a new prenylated arylbenzofuran named 7-(3-hydroxy-3-methylbutyl)moracin M (1) and two congeners, moracins P (2) and M (3). When compared to acarbose (IC50 = 486 µM), all the isolated compounds are better inhibitors of α-glucosidase with in vitro IC50 values of 16.9, 16.6, and 40.9 µM, respectively. However, they were not active against α-amylase. The compounds also demonstrated moderate inhibition of dipeptidyl peptidase-4 (DPP4). Based on in silico docking studies, all isolates (1, 2, and 3) exhibit binding affinities of −8.7, −9.5, and −8.5 kcal/mol, respectively against α-glucosidase enzyme (PDB: 3AJ7). They are stabilized within the α-glucosidase active site through hydrogen bonds, pi interactions, and hydrophobic interactions. This study provides scientific support for the traditional use of Morus mesozygia in the treatment of diabetes as well as adding to the repository of α-glucosidase inhibitory agents.https://www.frontiersin.org/articles/10.3389/fphar.2024.1338333/fullMorus mesozygiaAfrican traditional medicineroot bark extractarylbenzofuranα-glucosidaseα-amylase |
| spellingShingle | Katherine Olabanjo Olufolabo Katherine Olabanjo Olufolabo Kai Lüersen Samuel Ayoolu Oguntimehin Vaderament-A. Nchiozem-Ngnitedem Emmanuel Ayodeji Agbebi Kolade Olatubosun Faloye Divinah Kwamboka Nyamboki Gerald Rimbach Josphat Clement Matasyoh Bernd Schmidt Jones Olanrewaju Moody In vitro and in silico studies reveal antidiabetic properties of arylbenzofurans from the root bark of Morus mesozygia Stapf Frontiers in Pharmacology Morus mesozygia African traditional medicine root bark extract arylbenzofuran α-glucosidase α-amylase |
| title | In vitro and in silico studies reveal antidiabetic properties of arylbenzofurans from the root bark of Morus mesozygia Stapf |
| title_full | In vitro and in silico studies reveal antidiabetic properties of arylbenzofurans from the root bark of Morus mesozygia Stapf |
| title_fullStr | In vitro and in silico studies reveal antidiabetic properties of arylbenzofurans from the root bark of Morus mesozygia Stapf |
| title_full_unstemmed | In vitro and in silico studies reveal antidiabetic properties of arylbenzofurans from the root bark of Morus mesozygia Stapf |
| title_short | In vitro and in silico studies reveal antidiabetic properties of arylbenzofurans from the root bark of Morus mesozygia Stapf |
| title_sort | in vitro and in silico studies reveal antidiabetic properties of arylbenzofurans from the root bark of morus mesozygia stapf |
| topic | Morus mesozygia African traditional medicine root bark extract arylbenzofuran α-glucosidase α-amylase |
| url | https://www.frontiersin.org/articles/10.3389/fphar.2024.1338333/full |
| work_keys_str_mv | AT katherineolabanjoolufolabo invitroandinsilicostudiesrevealantidiabeticpropertiesofarylbenzofuransfromtherootbarkofmorusmesozygiastapf AT katherineolabanjoolufolabo invitroandinsilicostudiesrevealantidiabeticpropertiesofarylbenzofuransfromtherootbarkofmorusmesozygiastapf AT kailuersen invitroandinsilicostudiesrevealantidiabeticpropertiesofarylbenzofuransfromtherootbarkofmorusmesozygiastapf AT samuelayooluoguntimehin invitroandinsilicostudiesrevealantidiabeticpropertiesofarylbenzofuransfromtherootbarkofmorusmesozygiastapf AT vaderamentanchiozemngnitedem invitroandinsilicostudiesrevealantidiabeticpropertiesofarylbenzofuransfromtherootbarkofmorusmesozygiastapf AT emmanuelayodejiagbebi invitroandinsilicostudiesrevealantidiabeticpropertiesofarylbenzofuransfromtherootbarkofmorusmesozygiastapf AT koladeolatubosunfaloye invitroandinsilicostudiesrevealantidiabeticpropertiesofarylbenzofuransfromtherootbarkofmorusmesozygiastapf AT divinahkwambokanyamboki invitroandinsilicostudiesrevealantidiabeticpropertiesofarylbenzofuransfromtherootbarkofmorusmesozygiastapf AT geraldrimbach invitroandinsilicostudiesrevealantidiabeticpropertiesofarylbenzofuransfromtherootbarkofmorusmesozygiastapf AT josphatclementmatasyoh invitroandinsilicostudiesrevealantidiabeticpropertiesofarylbenzofuransfromtherootbarkofmorusmesozygiastapf AT berndschmidt invitroandinsilicostudiesrevealantidiabeticpropertiesofarylbenzofuransfromtherootbarkofmorusmesozygiastapf AT jonesolanrewajumoody invitroandinsilicostudiesrevealantidiabeticpropertiesofarylbenzofuransfromtherootbarkofmorusmesozygiastapf |